author-photo

Hiroaki Iijima

Mitsubishi Tanabe Pharma

19

Papers

435

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Association between Glycemic Control and Cardiovascular Events in Older Japanese Adults with Diabetes Mellitus: An Analysis of the Japanese Medical Administrative Database.

2021 Journal of Diabetes Investigation
Show All
- Source
- Cite
- Save
Citations (0)
SAT-358-Sodium glucose cotransporter 2 inhibitor, canagliflozin ameliorate liver function in Japanese patients with type 2 diabetes mellitus: Subgroup analyses of clinical trials

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice.

2019 Drugs
Show All
- Source
- Cite
- Save
Citations (12)
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

2018 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (21)
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus

2018 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Show All
- Source
- Cite
- Save
Citations (14)
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis

2018 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Show All
- Source
- Cite
- Save
Citations (43)
Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin

2018 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (26)
Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus

2017 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (65)
Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.

2017 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (37)
Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

2016 Cardiovascular Diabetology
Show All
- Source
- Cite
- Save
Citations (47)